Congenital myasthenic syndromes caused by mutations in acetylcholine receptor genes

Neurology

Volumn 48, Issue 4 SUPPL. 5, 1997, Pages

  Engel, Andrew G ^a   Ohno, Kinji ^a   Milone, Margherita ^a   Sine, Steven M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; MEMBRANE PROTEIN; RECEPTOR SUBUNIT;

BINDING KINETICS; CHANNEL GATING; CONFERENCE PAPER; DISEASE CLASSIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MYASTHENIA; NEUROMUSCULAR TRANSMISSION; NONSENSE MUTATION; PREDICTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR GENE; RECEPTOR OCCUPANCY;

EID: 0030898407     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.suppl_5.28s     Document Type: Conference Paper

References (50)

1. Rothbart HB. Myasthenia gravis. Familial occurrence. JAMA 1937;108:715-717.
2. Bundey S. A genetic study of infantile and juvenile myasthenia gravis. J Neurol Neurosurg Psychiatry 1972;35:41-51.
3. Engel AG, Lambert EH, Gomez MR. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol 1977;1:315-330.
4. Engel AG, Lambert EH, Mulder DM, et al. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 1982;11:553-569.
5. Engel AG, Lambert EH. Congenital myasthenic syndromes. Electroencephalogr Clin Neurophysiol 1987(suppl);39:91-102.
6. Mora M, Lambert EH, Engel AG. Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 1987;37:206-214.
7. Greer M, Schotland M. Myasthenia gravis in the newborn. Pediatrics 1960;26:101-108.
8. Robertson WC, Chun RWM, Kornguth SE. Familial infantile myasthenia. Arch Neurol 1980;37:117-119.
9. Magleby KL, Stevens CF. A quantitative description of end-plate currents. J Physiol (Lond) 1972;223:173-197.
10. Anderson CR, Stevens CF. Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction. J Physiol (Lond) 1973;235:655-691.
11. Engel AG, Uchitel O, Walls TJ, et al. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel. Ann Neurol 1993;34:38-47.
12. Uchitel O, Engel AG, Walls TJ, et al. Congenital myasthenic syndromes. II. A syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle Nerve 1993;16:1293-1301.
13. Milone M, Hutchinson DO, Engel AG. Patch-clamp analysis of the properties of acetylcholine receptor channels at the normal human endplate. Muscle Nerve 1994;17:1364-1369.
14. Engel AG. The investigation of congenital myasthenic syndromes. Ann NY Acad Sci 1993;681:425-434.
15. Engel AG. Myasthenic syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology, 2nd ed. New York: McGraw-Hill, 1994:1798-1835.
16. Ohno K, Hutchinson DO, Milone M, et al. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ∈ subunit. Proc Natl Acad Sci USA 1995;92:758-762.
17. Sine SM, Ohno K, Bouzat C, et al. Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 1995;15: 229-239.
18. Engel AG, Ohno K, Milone M, et al. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996;5:1217-1227.
19. Gomez CM, Maselli R, Gammack J, et al. A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Ann Neurol 1996;39:712-723.
20. Ohno K, Wang H-L, Milone M, et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ∈ subunit. Neuron 1996;17:157-170.
21. Ohno K, Brengman JM, Hutchinson DO, et al. A congenital myasthenic syndrome with two distinct nonsense mutations in the epsilon subunit of the acetylcholine receptor. Muscle Nerve 1994;17(suppl 1):S226.
22. Ohno K, Engel AG, Milone M, et al. A congenital myasthenic syndrome with severe acetylcholine receptor deficiency caused by heteroallelic frameshifting mutations in the epsilon subunit [abstract]. Neurology 1995;45(suppl 4):A283.
23. Milone M, Ohno K, Pruitt JN, et al. Congenital myasthenic syndrome due to frameshifting acetylcholine receptor epsilon subunit mutation [abstract]. Soc Neurosci Abstr 1996;22:1942.
24. Ohno K, Fukudome T, Nakano S, et al. Mutational analysis in a congenital myasthenic syndrome reveals a novel acetylcholine receptor epsilon subunit mutation [abstract]. Soc Neurosci Abstr 1996;22:234.
25. Engel AG, Ohno K, Bouzat C, et al. End-plate acetylcholine receptor deficiency due to nonsense mutations in the ∈ subunit. Ann Neurol 1996;40:810-817.
26. Hall ZW, Sanes JR. Synaptic structure and development: the neuromuscular junction. Cell 1993;72(suppl):99-121.
27. Phillips WD. Acetylcholine receptors and the cytoskeletal connection. Clin Exp Pharmacol Physiol 1995;22:961-965.
28. Gautam M, Noakes PG, Mudd J, et al. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 1995;377:232-236.
29. Gillespie SKH, Balasubramanian S, Fung ET, et al. Rapsyn clusters and activates the synapse-specific receptor tyrosine kinase MuSK. Neuron 1996;16:953-962.
30. Gautam M, Noakes PG, Moscoso L, et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 1996;85:525-535.
31. Kerr JFR, Gobé GC, Winterford CM, et al. Anatomical methods in cell death. Methods Cell Biol 1995;46:1-27.
32. Engel AG, Hutchinson DO, Nakano S, et al. Myasthenic syndromes attributed to mutations affecting the epsilon subunit of the acetylcholine receptor. Ann NY Acad Sci 1993;681:496-508.
33. von Heijne G. Proline kinks in transmembrane α-helices. J Mol Biol 1991;218:499-503.
34. O'Neil KT, DeGrado FW. A thermodynamic scale for the helix forming tendencies of the commonly occurring amino acids. Science 1990;250:646-651.
35. Ohno K, Hutchinson DO, Milone M, et al. Molecular genetic basis of a slow channel syndrome [abstract]. Muscle Nerve 1995;18:463.
36. Milone M, Ohno K, Wang H-L, et al. Novel slow-channel syndrome due to mutation in the acetylcholine receptor alpha subunit with increased conductance, nanomolar affinity for acetylcholine, and prolonged open durations of the AChR channel. Ann Neurol 1996;40:956.
37. Gomez CM, Gammack JT. A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 1995;45:982-985.
38. Maselli RA, Leung C. Analysis of anticholinesterase-induced neuromuscular transmission failure. Muscle Nerve 1993;16: 548-553.
39. Walls TJ, Engel AG, Nagel AS, et al. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann NY Acad Sci 1993;681:461-468.
40. Hutchinson DO, Walls TJ, Nakano S, et al. Congenital end-plate acetylcholinesterase deficiency. Brain 1993;116:633-653.
41. Camp S, Bon S, Li Y, et al. Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits. J Clin Invest 1995;95:333-340.
42. Oosterhuis HJGH, Newsom-Davis J, Wokke JHJ, et al. The slow channel syndrome. Two new cases. Brain 1987;110:1061-1079.
43. Engel AG, Nagel A, Walls TJ, et al. Congenital myasthenic syndromes. I. Deficiency and short open-time of the acetylcholine receptor. Muscle Nerve 1993;16:1284-1292.
44. Smit LME, Hageman G, Veldman H, et al. A myasthenic syndrome with congenital paucity of secondary synaptic clefts: CPSC syndrome. Muscle Nerve 1988;11:337-348.
45. Wokke JHJ, Jennekens FGI, Molenaar PC, et al. Congenital paucity of secondary synaptic clefts (CPSC) syndrome in 2 adult sibs. Neurology 1989;39:648-654.
46. Vincent A, Newsom-Davis J, Wray D, et al. Clinical and experimental observations in patients with congenital myasthenic syndromes. Ann NY Acad Sci 1993;681:451-460.
47. McQuillen MP. Familial limb-girdle myasthenia. Brain 1966; 89:121-132.
48. Goldhammer Y, Blatt I, Sadeh M, et al. Congenital myasthenia associated with facial malformations in Iraqi and Iranian jews. Brain 1990;113:1291-1306.
49. Unwin N. Neurotransmitter action: opening of ligand-gated ion channels. Cell 1993;72(suppl):31-41.
50. Akabas MH, Karlin A. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the α-subunit. Biochemistry 1995;34:12496-12500.